Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MCTA vs BTBT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MCTA
Charming Medical Limited Class A Ordinary Shares

Medical - Care Facilities

HealthcareNASDAQ • HK
Market Cap$445M
5Y Perf.+33.2%
BTBT
Bit Digital, Inc.

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$589M
5Y Perf.-31.2%

MCTA vs BTBT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MCTA logoMCTA
BTBT logoBTBT
IndustryMedical - Care FacilitiesFinancial - Capital Markets
Market Cap$445M$589M
Revenue (TTM)$6M$164M
Net Income (TTM)$1M$137M
Gross Margin67.2%61.9%
Operating Margin22.3%16.8%
Forward P/E414.5x9.2x
Total Debt$1M$14M
Cash & Equiv.$817K$95M

Quick Verdict: MCTA vs BTBT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BTBT leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Charming Medical Limited Class A Ordinary Shares is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MCTA
Charming Medical Limited Class A Ordinary Shares
The Long-Run Compounder

MCTA is the clearest fit if your priority is long-term compounding.

  • 319.3% 10Y total return vs BTBT's -60.4%
  • 19.3% margin vs BTBT's 17.3%
  • +319.3% vs BTBT's -9.0%
Best for: long-term compounding
BTBT
Bit Digital, Inc.
The Banking Pick

BTBT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 264.6%, EPS growth 225.0%
  • Lower volatility, beta 3.37, Low D/E 3.0%, current ratio 5.39x
  • Beta 3.37, yield 0.3%, current ratio 5.39x
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthBTBT logoBTBT264.6% NII/revenue growth vs MCTA's 3.4%
ValueBTBT logoBTBTLower P/E (9.2x vs 414.5x)
Quality / MarginsMCTA logoMCTA19.3% margin vs BTBT's 17.3%
Stability / SafetyBTBT logoBTBTLower D/E ratio (3.0% vs 23.6%)
DividendsBTBT logoBTBT0.3% yield; the other pay no meaningful dividend
Momentum (1Y)MCTA logoMCTA+319.3% vs BTBT's -9.0%
Efficiency (ROA)MCTA logoMCTA23.4% ROA vs BTBT's 19.0%, ROIC 265.0% vs 6.5%

MCTA vs BTBT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MCTACharming Medical Limited Class A Ordinary Shares

Segment breakdown not available.

BTBTBit Digital, Inc.
FY 2024
Other Member
100.0%$550,260

MCTA vs BTBT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMCTALAGGINGBTBT

Income & Cash Flow (Last 12 Months)

MCTA leads this category, winning 4 of 4 comparable metrics.

BTBT is the larger business by revenue, generating $164M annually — 26.3x MCTA's $6M. Profitability is closely matched — net margins range from 19.3% (MCTA) to 17.3% (BTBT).

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
RevenueTrailing 12 months$6M$164M
EBITDAEarnings before interest/tax$166M
Net IncomeAfter-tax profit$137M
Free Cash FlowCash after capex-$448M
Gross MarginGross profit ÷ Revenue+67.2%+61.9%
Operating MarginEBIT ÷ Revenue+22.3%+16.8%
Net MarginNet income ÷ Revenue+19.3%+17.3%
FCF MarginFCF ÷ Revenue+2.2%-65.3%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+2.8%
MCTA leads this category, winning 4 of 4 comparable metrics.

Valuation Metrics

BTBT leads this category, winning 4 of 4 comparable metrics.

At 9.2x trailing earnings, BTBT trades at a 98% valuation discount to MCTA's 414.5x P/E. On an enterprise value basis, BTBT's 8.5x EV/EBITDA is more attractive than MCTA's 269.8x.

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
Market CapShares × price$445M$589M
Enterprise ValueMkt cap + debt − cash$446M$508M
Trailing P/EPrice ÷ TTM EPS414.55x9.15x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple269.80x8.49x
Price / SalesMarket cap ÷ Revenue71.60x3.60x
Price / BookPrice ÷ Book value/share9999.00x0.56x
Price / FCFMarket cap ÷ FCF3219.65x
BTBT leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

MCTA leads this category, winning 5 of 7 comparable metrics.

MCTA delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $21 for BTBT. BTBT carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCTA's 23.57x.

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
ROE (TTM)Return on equity+24.4%+21.4%
ROA (TTM)Return on assets+23.4%+19.0%
ROICReturn on invested capital+2.6%+6.5%
ROCEReturn on capital employed+3.4%+8.5%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage23.57x0.03x
Net DebtTotal debt minus cash$343,868-$81M
Cash & Equiv.Liquid assets$816,771$95M
Total DebtShort + long-term debt$1M$14M
Interest CoverageEBIT ÷ Interest expense66.54x
MCTA leads this category, winning 5 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

MCTA leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MCTA five years ago would be worth $41,929 today (with dividends reinvested), compared to $1,543 for BTBT. Over the past 12 months, MCTA leads with a +319.3% total return vs BTBT's -9.0%. The 3-year compound annual growth rate (CAGR) favors MCTA at 61.3% vs BTBT's -7.1% — a key indicator of consistent wealth creation.

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
YTD ReturnYear-to-date-0.0%-10.3%
1-Year ReturnPast 12 months+319.3%-9.0%
3-Year ReturnCumulative with dividends+319.3%-19.7%
5-Year ReturnCumulative with dividends+319.3%-84.6%
10-Year ReturnCumulative with dividends+319.3%-60.4%
CAGR (3Y)Annualised 3-year return+61.3%-7.1%
MCTA leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

MCTA leads this category, winning 1 of 1 comparable metric.

MCTA currently trades 92.6% from its 52-week high vs BTBT's 40.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
Beta (5Y)Sensitivity to S&P 5003.37x
52-Week HighHighest price in past year$31.70$4.55
52-Week LowLowest price in past year$4.30$1.25
% of 52W HighCurrent price vs 52-week peak+92.6%+40.2%
RSI (14)Momentum oscillator 0–10078.569.1
Avg Volume (50D)Average daily shares traded018.5M
MCTA leads this category, winning 1 of 1 comparable metric.

Analyst Outlook

Insufficient data to determine a leader in this category.

BTBT is the only dividend payer here at 0.31% yield — a key consideration for income-focused portfolios.

MetricMCTA logoMCTACharming Medical …BTBT logoBTBTBit Digital, Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$5.00
# AnalystsCovering analysts2
Dividend YieldAnnual dividend ÷ price+0.3%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.01
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

MCTA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BTBT leads in 1 (Valuation Metrics).

Best OverallCharming Medical Limited Cl… (MCTA)Leads 4 of 6 categories
Loading custom metrics...

MCTA vs BTBT: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is MCTA or BTBT a better buy right now?

For growth investors, Bit Digital, Inc.

(BTBT) is the stronger pick with 264. 6% revenue growth year-over-year, versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). Bit Digital, Inc. (BTBT) offers the better valuation at 9. 2x trailing P/E, making it the more compelling value choice. Analysts rate Bit Digital, Inc. (BTBT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MCTA or BTBT?

On trailing P/E, Bit Digital, Inc.

(BTBT) is the cheapest at 9. 2x versus Charming Medical Limited Class A Ordinary Shares at 414. 5x.

03

Which is the better long-term investment — MCTA or BTBT?

Over the past 5 years, Charming Medical Limited Class A Ordinary Shares (MCTA) delivered a total return of +319.

3%, compared to -84. 6% for Bit Digital, Inc. (BTBT). Over 10 years, the gap is even starker: MCTA returned +319. 3% versus BTBT's -60. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MCTA or BTBT?

On balance sheet safety, Bit Digital, Inc.

(BTBT) carries a lower debt/equity ratio of 3% versus 24% for Charming Medical Limited Class A Ordinary Shares — giving it more financial flexibility in a downturn.

05

Which is growing faster — MCTA or BTBT?

By revenue growth (latest reported year), Bit Digital, Inc.

(BTBT) is pulling ahead at 264. 6% versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). On earnings-per-share growth, the picture is similar: Bit Digital, Inc. grew EPS 225. 0% year-over-year, compared to 54. 2% for Charming Medical Limited Class A Ordinary Shares. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MCTA or BTBT?

Charming Medical Limited Class A Ordinary Shares (MCTA) is the more profitable company, earning 19.

3% net margin versus 17. 3% for Bit Digital, Inc. — meaning it keeps 19. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCTA leads at 22. 3% versus 16. 8% for BTBT. At the gross margin level — before operating expenses — MCTA leads at 67. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — MCTA or BTBT?

In this comparison, BTBT (0.

3% yield) pays a dividend. MCTA does not pay a meaningful dividend and should not be held primarily for income.

08

Is MCTA or BTBT better for a retirement portfolio?

For long-horizon retirement investors, Charming Medical Limited Class A Ordinary Shares (MCTA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+319.

3% 10Y return). Bit Digital, Inc. (BTBT) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MCTA: +319. 3%, BTBT: -60. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between MCTA and BTBT?

These companies operate in different sectors (MCTA (Healthcare) and BTBT (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MCTA is a small-cap quality compounder stock; BTBT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MCTA

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 11%
Run This Screen
Stocks Like

BTBT

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 132%
  • Net Margin > 10%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MCTA and BTBT on the metrics below

Revenue Growth>
%
(MCTA: 3.4% · BTBT: 264.6%)
Net Margin>
%
(MCTA: 19.3% · BTBT: 17.3%)
P/E Ratio<
x
(MCTA: 414.5x · BTBT: 9.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.